Huiyi Zhu, M.S.

Associate Director of Field Application Scientist, GenScript Probio 

Steve Yang, M.S., M.B.A.

Co-Founder and Chief Executive Officer, Mianus Capital 

Haishan Xiong, Ph.D.

Chief executive officer,Panorama Medicine

Lauren Woodard, Ph.D.

Assistant Professor, Vanderbilt University Medical Center

Sumit Verma, M.E.M.

Senior Vice President Global Strategic Manufacturing, Iovance 

Lou Tonon

Senior Associate, Scheer Partners 

Xiulian Sun, Ph.D.

Founder and Chief Technical Officer, uBriGene Biosciences Inc. 

Kate Sullivan

Vice President of Business Investment and Regional Marketing, The Chamber of Commerce for Greater Philadelphia 

Andreas Solomos, Ph.D.

Director, WuXi Advanced Therapies 

Kathleen M. Shay, B.A., J.D.

Partner, Duane Morris LLP

Mark Rohlfing, M.S.

Vice President of Operations, Almac Clinical Services 

Bryan Poltilove, M.B.A.

Operating Partner, BroadOak Capital Partners 

Pan Pan, Ph.D., M.B.A.

Director of Business Development, Akeso Inc. 

Marian Nakada, Ph.D.

Vice President Venture Investments, Johnson & Johnson Innovation – JJDC  

Jolly Mazumdar, Ph.D., M.B.A.

Co-Founder and former chief executive officer, Chimeron Bio 

Danuta Jarocha, Ph.D.

Senior Research Investigator, University of Pennsylvania 

Vasant Jadhav, Ph.D

Senior Vice President, Alnylam Pharmaceuticals

Rebecca Guzman

Partner, Vice Chair of M&A Division, Duane Morris LLP

Stephen Gacheru, Ph.D.

Vice President, Biologics, Gene & Cell Therapy Operations, Frontage Laboratories, Inc 

Yiyu Dong, Ph.D.

Associate Director, WuXi Advanced Therapies 

Robert Dickey, M.B.A.

Managing Director, Foresite Advisors 

John Chuckalovcak, M.S.

Associate Director, dPCR Business Development, QIAGEN Inc.

Yi-Yen Chen, Ph.D.

Associate Director, PCI Ventures, Pen Center for Innovation 

Susan Chase

Vice President of Business Development , BioLabs

David Chang, Ph.D.

President and Chief Technical Officer, WuXi Advanced Therapies 

Cynthia Cai, Ph.D., M.B.A.

Venture Partner, Viva BioInnovator; President, Tharton Consulting

Yuxiang Huang, Ph.D.

Senior Director, WuXi Advanced Therapies

Pengfei Yuan, Ph.D.

Chief Technology Officer, EdiGene Inc

Yang Xiang, Ph.D

Senior Field Application Scientist, GenScript Biotech Corporation

Li Ou, Ph.D.

Vice President, Genemagic Biosciences

Mandy Xie

Executive Director, Bristol Myers Squibb, Cell Therapy Development

Rongze Yang, Ph.D.

Director of Vector Engineering & Production, AAVnerGene Inc.

Fang Shen, Ph.D.

VP of Research & Translational Biology, Immunome

Haoyan (Michael) Zhou, Ph.D.

Research Formulation Lead, Spark Therapeutics

Roland Kolbeck

CSO, Spirovant Sciences

Chuansong Wang

VP – Process Sciences, Adverum Biotechnologies, Inc.

Anh Nguyen

Vice President, Therapeutic Sector Lead, Asklepios Biopharmaceutical (AskBio)

Francesco Bibbiani, M.D.

Senior Vice President, Head of Development, Dyne Therapeutics

Qinghua (Jenny) Zhao

Executive Director, Forecyte Bio

Jinpian Diao-Piezunka

Head of Technical Development, Spark Therapeutics

Zhiping Liu, J.D.

Founder, Chen & Hoffman LLP

Tom Gordon, M.B.A.

Managing Director, Silicon Valley Bank

Matthew Reber, M.S., M.B.A.

Partner, 1315 Capital

Hugh Davis, Ph.D.

Chief Operating Officer & President, Biosion USA, Inc.

Amanda L. Hays, Ph.D.

Scientific Officer, BioAgilytix Labs

Xianxin Hua, M.D., Ph.D.

Professor of Cancer Biology, University of Pennsylvania

Parimal Pande, Ph.D.

Associate Scientific director at Janssen Pharmaceuticals

Venkata Vepachedu, Ph.D.

Associate Scientific Director, Janssen Pharmaceuticals

Leyuan Ma, Ph.D.

Assistant Professor, University of Pennsylvania and Children's Hospital of Philadelphia

Michael Klichinsky, Ph.D.

Chief Scientific Officer, Carisma Therapeutics

Dongfang Liu, Ph.D.

Associate Professor, Rutgers University

Xiao Wang, Ph.D.

Research Assistant Professor, University of Pennsylvania

Marc Abrams, Ph.D.

Chief Scientific Officer, Carbon Biosciences

Lili Wang, Ph.D.

Research Associate Professor, University of Pennsylvania

Karen Kozarsky, Ph.D.

Chief Scientific Officer & Founder, SwanBio Therapeutics

Sheila Mikhail, J.D., M.B.A.

Co-Founder, Former CEO, AskBio

Katherine High, M.D.

Visiting Professor at Rockefeller University in New York

Lijun Wang

CEO, CoJourney Bio

Jim Wilson, M.D., Ph.D.

Director, Gene Therapy Program

Leo Qian, Ph.D.

Co-founder and Vice President, Discovery Research at Entrada Therapeutics

Peixin Zhu, Ph.D.

VP of R&D at Tevard Biosciences

Husain Attarwala, Ph.D.

VP, DMPK and Clinical Pharmacology at Aera Therapeutics

Federico Mingozzi, Ph.D.

Chief Science & Technology Officer at Spark Therapeutics

Eric Law

Head of CMC Regulatory Affairs at Century Therapeutics

Adam Pfendt, M.ChE

Senior Director of Process Development at Carisma Therapeutics

Ohnmar Khanal, Ph.D.

Process Development Downstream Technology Lead at Sparks Therapeutics

Lisa Berger Baskin, B.S.

SVP, Scheer Partners, Inc.

Chaohong Fan, Ph.D, M.D.

Lead Oncology Medical Officer, FDA

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, FDA